Janet K. Snell-Bergeon
Anschutz Medical Campus
244 Papers
931 Citations
Janet K. Snell-Bergeon is an academic researcher from Anschutz Medical Campus. The author has contributed to research in topics: Diabetes mellitus & Type 1 diabetes. The author has an hindex of 44, co-authored 185 publications. Previous affiliations of Janet K. Snell-Bergeon include University of Colorado Boulder & Colorado School of Public Health.
Chat about Author
Papers
Health Care Professionals' Perspectives on Use of Diabetes Technologies for Managing Visually Impaired Patients With Diabetes.
TL;DR: Voice-activation feature of G6 CGM is underutilized and providers who used the system reported positive outcomes in visually impaired patients, suggesting theCGM is the preferred glucose monitoring method for managing visually impaired Patients with diabetes.
1
Elevated Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Intrarenal Hemodynamic Dysfunction in Type 1 Diabetes (T1D)
Petter Bjornstad,Janet K. Snell-Bergeon,Julie A. Lovshin,Sunita K. Singh,Leif E. Lovblom,Josephine Tse,Andrej Orszag,Yuliya Lytvyn,Michael H. Brent,Narinder Paul,Alanna Weisman,Hillary A. Keenan,Leslie Cham,Vera Bril,Bruce A. Perkins,David Z.I. Cherney +15 more
TL;DR: Elevated NGAL is related to intrarenal hemodynamic dysfunction and afferent vasoconstriction in longstanding T1D.
1
226-OR: Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes—A Seven-Year Longitudinal Study
Viral N. Shah,Casey Sakamoto,Laura Pyle,Halis Kaan Akturk,Sarit Polsky,Gregory P. Forlenza,Janet K. Snell-Bergeon +6 more
TL;DR: Forlenza et al. as discussed by the authors analyzed up to 7 years of retrospective longitudinal continuous glucose monitoring (CGM) data of 90 adults with type 1 diabetes (T1D) without a diagnosis of diabetic retinopathy (DR) (Control group) and 70 adults with new incident diagnosis of DR between June 2018-December 2020 but had normal eye examinations in the past (DR group).
1
99-OR: HbA1c Variability Predicts Both Coronary Atherosclerosis and CVD Events in Type 1 Diabetes
TL;DR: HbA 1c variability may be a risk factor for both coronary atherosclerosis and CVD events in T1D, and the appropriate care strategy for this population may include maintaining an HbA1c value over time that is both at-target and stable.
1
Abstract P162: Cardiovascular Disease And Periodontal Disease In Type 1 Diabetes
TL;DR: To determine how subclinical measures of cardiovascular disease differ by diabetes status and how they are related to the extent of periodontal disease, it is hypothesized that people with T1D will have stiffer vessels with higher pulse wave velocity (PWV), lower brachial artery distensibility (BrachD), and higher carotid intima-media thickness (cIMT) compared to non-diabetic controls.